COMMUNIQUÉS West-GlobeNewswire

PCI Biotech: Invitation to full year 2017 presentation
13/03/2018
Oslo, 13 March 2018 - PCI Biotech invites to a presentation of the company's full year 2017 report on Tuesday 20 March 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday March 20, 08:30am - 09:30am CET (local [...]
Athersys and Healios Announce Binding Letter of Intent to Expand MultiStem® Collaboration
13/03/2018
Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated development of MultiStem [...]
UPDATE -- Immuron Commences US Non-Deal Institutional Investor Roadshow
13/03/2018
MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC)(NASDQ:IMRN) is pleased to release to shareholders and investors its latest Company [...]
Kiadis Pharma N. V.: Kiadis Pharma raises €23.4 million in a private placement of 2.6 million new shares
13/03/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION [...]
Gallup and Sharecare Announce Annual Community Rankings
13/03/2018
ATLANTA, March 13, 2018 (GLOBE NEWSWIRE) -- Sharecare , the digital health company that helps people manage all their health in one place, and world-leading analytics and advice firm, Gallup , today reported their [...]
MediciNova to Participate in Business Development Panel Session at the BIO Asia International Conference in Tokyo
13/03/2018
LA JOLLA, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875 [...]
Genocea Appoints Narinder Singh as SVP Pharmaceutical Sciences & Manufacturing
12/03/2018
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced the appointment of Narinder Singh as [...]
Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program
12/03/2018
Single dose of vaccine showed 67% survival rate and 100% survival rate after two doses GAITHERSBURG, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, [...]
ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017
12/03/2018
ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017 Conference call and webcast on Tuesday, March 13 th at 1:30 pm CET/8:30 am EDT Reported positive data from Phase 2b clinical trial of [...]
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipids and Inflammatory Markers in Patients With Persistent High Triglycerides and Elevated High-Sensitivity C-Reactive Protein (hsCRP)
12/03/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, March 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs
12/03/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, March 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Precision Therapeutics Appoints Kevin Hungerford as Vice President of Sales and Marketing
12/03/2018
MINNEAPOLIS, March 12, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, announced today that it has appointed Kevin Hungerford as Global Vice [...]
Epizyme Appoints Oncology Industry Leader Michael Giordano, M.D., to its Board of Directors
12/03/2018
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced the appointment of Michael Giordano, M. [...]
Arch Therapeutics Provides Update on 510(k)
12/03/2018
FRAMINGHAM, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, today announced that it has [...]
Scythian Biosciences Announces 4-For-1 Stock Split and Appointment of Vic Neufeld as New Chairman of the Board of Directors
12/03/2018
TORONTO, March 12, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) announces that, further to its press release on March 9, [...]
Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection
12/03/2018
WALTHAM, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine [...]
Vericel to Host Analyst and Investor Day on April 11, 2018
12/03/2018
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that it will host an [...]
Teligent, Inc. to Hold Conference Call for Fourth Quarter 2017 Results
12/03/2018
BUENA, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Thursday [...]
VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange
12/03/2018
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. ("VBI" or the "Company") (Nasdaq: VBIV ) (TSX: VBV ), a commercial-stage biopharmaceutical company developing next-generation infectious disease and [...]

Pages